Equibles does not estimate personal net worth.
Get an email with a short summary when Milestone Pharmaceuticals Inc. publishes a filing, an earnings call transcript or a press release.
Get MIST alertsAnthony Crick has spoken on 1 earnings call across 1 company, most recently for Milestone Pharmaceuticals Inc. on November 13, 2026. Milestone Pharmaceuticals Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Milestone Pharmaceuticals Inc. includes Joseph Oliveto (CEO and Board Member), Amit Hasija (CFO), Jeffrey Nelson (COO) and 7 others.
“Net product revenue was $1.0 million for the third quarter of 2026, compared with $0.6 million in the second quarter of 2026. For the nine months ended September 30, 2026, net product revenue was $1.8 million.”
Transcript header (unverified)
Biotechnology · Healthcare
